XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Stock-Based Compensation | 3 Months Ended
--- | ---
Mar. 31, 2017
Stock-Based Compensation [Abstract] |
Stock-Based Compensation | ﻿ NOTE 7 – STOCK-BASED COMPENSATION The Company has issued awards under three stock-based compensation plans (the “Plans”), as described below. Total compensation cost that has been charged against income for those Plans totaled $61 and $30, respectively, for the three months ended March 31, 201 7 and 201 6. The total income tax effect was $21 and $8, respectively, for the three months ended March 31, 201 7 and 201 6. The Plans are all stockholder-approved and authorize stock option grants and restricted stock awards to be made to directors, officers and employees. The 1999 Stock-Based Incentive Plan, which expired July 13, 2009, provided 38,778 shares of common stock for stock option grants and 15,511 shares of common stock for restricted stock awards. The 2003 Equity Compensation Plan (the “2003 Plan”), as amended and restated, provided an aggregate of 100,000 shares for stock option grants and restricted stock awards, of which up to 30,000 shares could be awarded in the form of restricted stock awards. The 2009 Equity Compensation Plan (the “2009 Plan”), which was approved by stockholders on May 21, 2009, replaced the 2003 Plan and provided for 200,000 shares, plus any remaining shares available to grant or that are later forfeited or expire under the 2003 Plan, to be made available to be issued as stock option grants, stock appreciation rights or restricted stock awards. On May 16, 2013, the Company’s stockholders approved the First Amendment to the 2009 Plan to increase the number of shares of common stock reserved for stock option grants and restricted stock awards thereunder to 1,500,000. ﻿ Stock Options: The Plans permit the grant of stock options to directors, officers and employees of the Holding Company and CFBank. Option awards are granted with an exercise price equal to the market price of the Company’s common stock on the date of grant, generally have vesting periods ranging from one to three years, and are exercisable for ten years from the date of grant. Unvested stock options immediately vest upon a change of control. The fair value of each option award is estimated on the date of grant using a closed form option valuation (Black-Scholes) model that uses the assumptions noted in the table below. Expected volatilities are based on historical volatilities of the Company’s common stock. The Company uses historical data to estimate option exercise and post-vesting termination behavior. Employee and management options are tracked separately. The expected term of options granted is based on historical data and represents the period of time that options granted are expected to be outstanding, which takes into account that the options are not transferable. The risk-free interest rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant. There were no options granted or exercised during the three months ended March 31, 201 7 and March 31, 201 6 (unaudited). A summary of stock option activity in the Plans for the three months ended March 31, 201 7 follows (unaudited):
﻿ |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |
﻿ | Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term (Years) |  | Intrinsic Value
﻿Outstanding at beginning of year | 542,746 |  | $ | 1.46 |  |  |  |  |
﻿Expired | (300) |  |  | 36.75 |  |  |  |  |
﻿Outstanding at end of period | 542,446 |  | $ | 1.44 |  | 6.2 |  | $ | 407,470
﻿ |  |  |  |  |  |  |  |  |
﻿Expected to vest | - |  | $ | - |  | - |  | $ | -
﻿ |  |  |  |  |  |  |  |  |
﻿Exercisable at end of period | 542,446 |  | $ | 1.44 |  | 6.2 |  | $ | 407,470
﻿ During the three months ended March 31, 201 7, there were 300 stock options that expired. There were no expired stock options during the three months ended March 31, 2016. During the three months ended March 31, 2017, there were no cancelled or forfeited stock options compared to 7,500 for the three months ended at March 31, 2016. Previously recognized expense associated with nonvested forfeited shares was reversed. As of March 31, 2017, all stock options granted under the Plans were vested. Restricted Stock Awards: The Plans permit the grant of restricted stock awards to directors, officers and employees. Compensation is recognized over the vesting period of the awards based on the fair value of the stock at grant date. The fair value of the stock is determined using the closing share price on the date of grant and shares generally have vesting periods of one to three years. There were no shares of restricted stock issued during the three months ended March 31, 201 7 and 201 6 (unaudited). A summary of changes in the Company’s nonvested restricted shares for the year follows (unaudited): ﻿
﻿ |  |  |  |
﻿ |  |  |  |
﻿Nonvested Shares | Shares |  | Weighted Average Grant-Date Fair Value
﻿Nonvested at January 1, 2017 | 425,666 |  | $ | 1.56
﻿Forfeited | (6,333) |  |  | 1.50
﻿Nonvested at March 31, 2017 | 419,333 |  | $ | 1.56
﻿ As of March 31, 201 7 and 201 6, the unrecognized compensation cost related to nonvested restricted stock awards granted under the Plans was $572 and $237, respectively. ﻿ There were 6,333 shares of restricted stock forfeited during the three months ended March 31, 201 7. There were no shares of restricted stock forfeited during the three months ended March 31, 201 6. Also, there were no shares that vested during the three months ended March 31, 201 7 and 201 6. There were 546,425 shares remaining available for stock option grants and restricted stock awards under the 2009 Plan at March 3 1, 201 7.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration